Retraction Note: Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin

Authors:

Abstract
No abstract available

This publication has 1 reference indexed in Scilit: